Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.54 |
| ▸ | NOS1 | P29475 | 1/20 | 0.54 |
| ▸ | NOS2 | P35228 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.50 |
| ▸ | METAP2 | P50579 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | TDP2 | O95551 | 1/20 | 0.38 |
| ▸ | NSD2 | O96028 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29924154 | 0.85 | CYP2A6 (0.61) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL196235 | 0.85 | CYP2A6 (0.61) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL31252534 | 0.85 | CYP2A6 (0.61) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL12320090 | 0.85 | CYP2A6 (0.48) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL2642064 | 0.85 | NOS3 (0.54) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL31175943 | 0.83 | CYP2A6 (0.47) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL4159050 | 0.82 | CYP2A6 (0.43) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL17589450 | 0.82 | CYP2A6 (0.50) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL12319853 | 0.81 | CYP2A6 (0.46) | NOS3NOS1NOS2CYP2A6PDK2 | |
| SCHEMBL17014652 | 0.81 | CYP2A6 (0.50) | NOS3NOS1NOS2CYP2A6PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230345811-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-26 | — | — | US | disclosed |
| US-11746122-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-05 | — | — | US | disclosed |
| US-11737349-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230263049-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-17 | — | — | US | disclosed |
| US-20230147066-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-11 | — | — | US | disclosed |
| US-9847497-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-12-19 | — | — | US | disclosed |
| US-20150236279-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-20 | — | — | US | disclosed |
| US-8017774-B2 | Producing method for iridium complex | CANON KABUSHIKI KAISHA (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20070232803-A1 | PRODUCING METHOD FOR IRIDIUM COMPLEX | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150236279-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | MLX, ZYX, LOXL1 | NOS3 1807/4885NOS1 2366/4885NOS2 2839/4885 |
| US-11746122-B2 | Organic electroluminescent materials and devices | GLRA3, GLRA2, LIFR | NOS3 2003/4885NOS1 3259/4885NOS2 2862/4885 |
| US-11737349-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OTC | NOS3 1755/4885NOS1 1374/4885NOS2 1621/4885 |
| US-20230147066-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, SSB, MCOLN3 | NOS3 1273/4885NOS1 2270/4885NOS2 2568/4885 |
| US-20070232803-A1 | PRODUCING METHOD FOR IRIDIUM COMPLEX | LAGE3, EML4, INTS9 | NOS3 2606/4885NOS1 2030/4885NOS2 1281/4885 |
| US-20230263049-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, OCIAD1, OSBP | NOS3 904/4885NOS1 1950/4885NOS2 2000/4885 |
| US-20230345811-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OPRD1, L1CAM, OPRM1 | NOS3 2364/4885NOS1 3055/4885NOS2 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.